Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2019.02.22, EP 19158774
ALAN K. DAVIS ET AL: "5-methoxy- N,N -dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety", AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, vol. 45, no. 2, 1 March 2019 (2019-03-01), US, pages 161 - 169, XP055695498, ISSN: 0095-2990, DOI: 10.1080/00952990.2018.1545024 (B1)
CARHART-HARRIS R L ET AL: "Psilocybin with psychological support for treatment-resistant depression: six-month follow-up", PSYCHOPHARMACOLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 235, no. 2, 8 November 2017 (2017-11-08), pages 399 - 408, XP036477494, ISSN: 0033-3158, [retrieved on 20171108], DOI: 10.1007/S00213-017-4771-X (B1)
OSÓRIO FDE L ET AL: "Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report", REVISTA BRASILEIRA DE PSIQUIATRIA, PUBL. SOLUTIONS, BR, vol. 37, no. 1, 1 January 2015 (2015-01-01), pages 13 - 20, XP009520464, ISSN: 1516-4446, DOI: 10.1590/1516-4446-2014-1496 (B1)
SHEN HONG-WU ET AL: "Nonlinear Pharmacokinetics of 5-Methoxy-N,N-dimethyltryptamine in Mice", vol. 39, no. 7, 30 June 2011 (2011-06-30), pages 1227 - 1234, XP009520579, ISSN: 0090-9556, Retrieved from the Internet <URL:http://dmd.aspetjournals.org/cgi/doi/10.1124/dmd.111.039107> DOI: 10.1124/DMD.111.039107 (B1)
WO-A1-2019/081764 (B8)
UTHAUG MALIN V ET AL: "Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment", PSYCHOPHARMACOLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 237, no. 3, 10 December 2019 (2019-12-10), pages 773 - 785, XP037030419, ISSN: 0033-3158, [retrieved on 20191210], DOI: 10.1007/S00213-019-05414-W (B1)
GEYER M A ET AL: "Behavioural and pharmacological studies of pharmahuasca in rodents", EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 26, 2016, XP029787110, ISSN: 0924-977X, DOI: 10.1016/S0924-977X(16)30889-6 (B8)
WO-A1-2018/195455 (B8)
THOMAS G ET AL: "Ayahuasca-assisted therapyfor addiction: results from a preliminary observational study in Canada", CURRENT DRUG ABUSE REVIEWSE, BENTHAM SCIENCE PUBLISHERS LTD, vol. 6, no. 1, 1 March 2013 (2013-03-01), pages 30 - 42, XP009520465, ISSN: 1874-4737, DOI: 10.2174/15733998113099990003 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP3927337)
|
Innkommende
Korrespondanse (Hovedbrev inn)
|
Utgående
EP Formelle mangler
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Neste fornyelse/årsavgift:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 6. avg. år (EP) | 2025.02.25 | 2600 | CPA GLOBAL LIMITED | Betalt og godkjent |
32405847 expand_more expand_less | 2024.05.02 | 7150 | ZACCO NORWAY AS | Betalt |
Valideringsgebyr EP-patent
7150 = 1 X 7150
|
||||
Årsavgift 5. avg. år (EP) | 2024.04.24 | 2150 | ZACCO NORWAY AS | Betalt og godkjent |